Nijhof IS, van Bueren JJL, van Kessel B, Andre P, Morel Y, Lokhorst HM, van de Donk NW, Parren PW, Mutis T. Daratumumab-mediated lysis of primary multiple myeloma cells is enhanced in combination with the human anti-KIR antibody IPH2102 and lenalidomide. Haematologica [Internet]. 2015Jan.31 [cited 2026Nov.6];100(2):263-8. Available from: https://haematologica.org/article/view/7285